CASI Pharmaceuticals, Inc (DE) of ROCKVILLE, MD filed a DEF 14A with the SEC on 2023-02-14. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
Showing 12 of 43 filings.
| Filed | Form |
|---|---|
| 2023-02-14 | DEF 14A |
| 2022-04-15 | DEF 14A |
| 2022-04-04 | PRE 14A |
| 2021-06-07 | DEFA14A |
| 2021-06-02 | PX14A6G |
| 2021-05-10 | DEF 14A |
| 2021-04-30 | PRE 14A |
| 2020-04-22 | DEF 14A |
| 2019-04-30 | DEF 14A |
| 2019-04-05 | PRE 14A |
| 2018-04-17 | DEF 14A |
| 2017-04-14 | DEF 14A |